U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C13H12O7S2.C4H10N2
Molecular Weight 430.496
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PIPERAZINE SULTOSYLATE

SMILES

C1CNCCN1.CC2=CC=C(C=C2)S(=O)(=O)OC3=CC=C(O)C(=C3)S(O)(=O)=O

InChI

InChIKey=HGAVKWUHBLHFNP-UHFFFAOYSA-N
InChI=1S/C13H12O7S2.C4H10N2/c1-9-2-5-11(6-3-9)22(18,19)20-10-4-7-12(14)13(8-10)21(15,16)17;1-2-6-4-3-5-1/h2-8,14H,1H3,(H,15,16,17);5-6H,1-4H2

HIDE SMILES / InChI

Description

Sultosilic acid is a benzenesulfonate ester. Sultosilic acid has been shown to be a hypolipidaemic drug both in animal experiments and in human clinical studies, chemically unrelated to other such drugs. The compound is being developed as a human drug (Mimedran ®) and is formulated as the piperazine salt (A-585). The recommended daily dose is three times one tablet containing 500 mg of Sultosilic acid.

Approval Year

Unknown
139594
PubMed

PubMed

TitleDatePubMed
Treatment of type IIb familial combined hyperlipidemia with the combination pravastatin-piperazine sultosilate.
2004 Aug 2
Rationale for combination therapy with statin drugs in the treatment of dyslipidemia.
2005 Feb

Sample Use Guides

In Vivo Use Guide
three times one tablet containing 500 mg of Sultosilic acid
Route of Administration: Oral
Name Type Language
PIPERAZINE SULTOSYLATE
Common Name English
SULTOSILIC ACID PIPERAZINE SALT [MI]
Common Name English
DIETHYLENEDIAMINE SULTOSYLATE
Common Name English
A-585
Code English
MIMEDRAN
Brand Name English
SULTOSILIC ACID PIPERAZINE SALT
MI   WHO-DD  
Common Name English
Sultosilic acid piperazine salt [WHO-DD]
Common Name English
BENZENESULFONIC ACID, 2-HYDROXY-5-(((4-METHYLPHENYL)SULFONYL)OXY)-, COMPD. WITH PIPERAZINE (1:1)
Systematic Name English
Code System Code Type Description
ECHA (EC/EINECS)
260-944-6
Created by admin on Fri Dec 15 15:46:49 GMT 2023 , Edited by admin on Fri Dec 15 15:46:49 GMT 2023
PRIMARY
EPA CompTox
DTXSID70973358
Created by admin on Fri Dec 15 15:46:49 GMT 2023 , Edited by admin on Fri Dec 15 15:46:49 GMT 2023
PRIMARY
SMS_ID
100000087413
Created by admin on Fri Dec 15 15:46:49 GMT 2023 , Edited by admin on Fri Dec 15 15:46:49 GMT 2023
PRIMARY
PUBCHEM
162841
Created by admin on Fri Dec 15 15:46:49 GMT 2023 , Edited by admin on Fri Dec 15 15:46:49 GMT 2023
PRIMARY
FDA UNII
69PPS56Y93
Created by admin on Fri Dec 15 15:46:49 GMT 2023 , Edited by admin on Fri Dec 15 15:46:49 GMT 2023
PRIMARY
CAS
57775-27-6
Created by admin on Fri Dec 15 15:46:49 GMT 2023 , Edited by admin on Fri Dec 15 15:46:49 GMT 2023
PRIMARY
MERCK INDEX
m10394
Created by admin on Fri Dec 15 15:46:49 GMT 2023 , Edited by admin on Fri Dec 15 15:46:49 GMT 2023
PRIMARY Merck Index
ACTIVE MOIETY
Structure of SULTOSILIC ACID
PARENT (SALT/SOLVATE)
Structure of Piperazine
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966